Dolby Laboratories (DLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 09-2013 | 09-2012 | 09-2011 | 09-2010 | 09-2009 | |
| Sales | 909,674 | 933,014 | 961,065 | 922,713 | 719,503 |
| Cost of Goods | 96,719 | 92,027 | 111,171 | 131,815 | 64,768 |
| Gross Profit | 812,955 | 840,987 | 849,894 | 790,898 | 654,735 |
| Operating Expenses | 568,412 | 479,022 | 420,332 | 362,332 | 291,837 |
| Operating Income | 245,262 | 361,992 | 429,733 | 429,381 | 363,666 |
| Interest Expense | 575 | 196 | -1,027 | 703 | 935 |
| Other Income | 5,959 | 7,195 | 9,883 | 8,334 | 8,688 |
| Pre-tax Income | 250,646 | 368,991 | 440,643 | 437,012 | 371,419 |
| Income Tax | 60,344 | 103,857 | 130,061 | 154,185 | 127,073 |
| Net Income Continuous | 190,302 | 265,134 | 310,582 | 282,827 | 244,346 |
| Minority Interests | 1,031 | 832 | 1,315 | -620 | 1,355 |
| Net Income | $189,271 | $264,302 | $309,267 | $283,447 | $242,991 |
| EPS Basic Total Ops | 1.86 | 2.47 | 2.78 | 2.50 | 2.15 |
| EPS Basic Continuous Ops | 1.87 | 2.48 | 2.79 | 2.49 | 2.16 |
| EPS Diluted Total Ops | 1.84 | 2.46 | 2.75 | 2.46 | 2.11 |
| EPS Diluted Continuous Ops | 1.85 | 2.47 | 2.76 | 2.45 | 2.12 |
| EBITDA(a) | $308,741 | $423,008 | $490,815 | $473,436 | $397,987 |